This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

    More

    Page   1/6   
  • [VIDEO] The future of health care. It’s in your hands
    Discover a future where technology streamlines the health care experience for consumers, practitioners, hospitals, pharmacies and other stakeholders, by placing pertinent health data at their fingertips in real time.
  • Young adults and health insurance: Not invincible — but perhaps convincible
    Looking ahead to the next open enrollment season, how can health plans and government agencies entice young people to participate? According to Deloitte's 2014 Survey of Young Adults and Health Insurance, the answer may lie in information, affordability, and value.
  • In the face of uncertainty - Redefining biopharma innovation
    A recent Deloitte study has shown that the overall rate of return on R&D investment for the 12 largest biopharmaceutical firms has dropped significantly since 2010, and the cost of developing a new medicine has risen substantially. Learn more.
  • The four dimensions of effective mHealth: People, places, payment and purpose
    The promise of mHealth is profound but, as yet, unrealized. While the tools to deliver mHealth already reside in users’ hands, how do we bridge the gap from opportunity to adoption? In order for mHealth to reach its full potential, four critical dimensions must align: people, places, payment and purpose.
  • 3D opportunity in medical technology
    Additive manufacturing capabilities align well with the needs of the medical device segment, enhancing product customization and enabling efficient, cost-effective production and delivery.
  • 2014 Global life sciences sector outlook
    The report outlines the top issues facing global life sciences stakeholders, provides a snapshot of activity in a number of geographic markets, and suggests considerations for companies as they seek to grow revenue and market share in 2014 and beyond.
  • The quest for value in health care: A place for consumers
    Three key disrupters are driving an increasingly consumer-centric health care system. How are consumers responding? What are the implications for the industry? And what steps can health care providers, health plans and life sciences companies consider to help win in this new marketplace?
  • Update: Privacy and security of protected health information
    The permanent HIPAA audit program commences in 2014, and the importance of ongoing risk analysis is a central feature of these audits. Industry stakeholders should consider evaluating their HIPAA privacy and security controls as soon as possible.
  • Invigorating biopharma: How the three rules can drive superior performance
    Though changing industry dynamics may call for a focus on cost containment in the short term, biopharma companies can emerge with new strategies that are again oriented toward non-price value and growth.
  • Health care reform: Redefining biopharma innovation
    Health care reform encompasses legislation that has been signed in the recent past related to the access and delivery of healthcare, notably the Affordable Care Act (ACA) passed in 2010, as well as broader, nonreversible trends in the market. Reform culminates into a heightened focus on reducing cost while increasing the quality of care, which will likely force a new definition of innovation to emerge for biopharma.
  • Page   1/6